Boundless Bio to Participate in the Piper Sandler 37th Annual Healthcare Conference
(NASDAQ:BOLD), SAN DIEGO, Nov. 24, 2025 (GLOBE NEWSWIRE) — Boundless Bio, (Nasdaq: BOLD) a clinical-stage oncology company interrogating extrachromosomal DNA (ecDNA) biology to deliver transformative therapies to patients with previously intractable oncogene amplified cancers, today announced that Zachary Hornby, President and Chief Executive Officer, will participate in a fireside chat at the Piper Sandler 37th […]